Study Suggests Standard Breast Cancer Classification May Miss Critical Biological Differences
Source Summary
Researchers at Karolinska Institutet published findings in The Lancet Regional Health – Europe indicating that the conventional binary classification of breast cancer as estrogen receptor-positive or negative may not capture important biological variations among patients. The simplified classification system could overlook differences that influence treatment decisions. The study suggests a need to reconsider how breast cancer is categorized for clinical purposes.
Why it matters
Current breast cancer classification may lead to suboptimal treatment decisions if it fails to account for biological differences that affect patient outcomes.



